Impact Events
MoreDate | Lead Company | Event | Type | Approval Change | Approval Likelihood |
---|---|---|---|---|---|
8/17/22 | Sanofi (SNY) | Amcenestrant for Breast Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
8/15/22 | Novartis (NVS) | Ilaris for Non-Small Cell Lung Cancer (NSCLC) | Subscribers Only | Subscribers Only | Subscribers Only |
8/12/22 | Pfizer (PFE) | Prevnar 20 for Pneumococcal (Streptococcus pneumoniae) Vaccines (Antibacterial) | Subscribers Only | Subscribers Only | Subscribers Only |
8/12/22 | Aptinyx (APTX) | NYX-2925 for Fibromyalgia | Subscribers Only | Subscribers Only | Subscribers Only |
8/11/22 | NewAmsterdam | Obicetrapib for Dyslipidemia / Hypercholesterolemia | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
MoreExpected Date Range | Lead Company | Drug | Expected Catalyst |
---|---|---|---|
08/18/22 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
08/18/22 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
08/22/22 | Subscribers Only | Subscribers Only | Patent - Expiration |
08/25/22 - 08/27/22 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
08/26/22 - 08/28/22 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |